Literature DB >> 19295246

Scarless endoscopic papillomectomy of the breast.

Omer Bender1, Fatih Levent Balci, Enis Yüney, Hasan Akbulut.   

Abstract

BACKGROUND: Efforts have been made to improve minimally invasive breast surgery techniques, resulting in less tissue damage and much better cosmetic results. We evaluated the therapeutic value of a new scarless operation, endoscopic papillomectomy (EP), in patients with pathologic nipple discharge (PND).
METHODS: Breast ductoscopy was performed on 126 women with PND. These patients underwent a variety of appropriate ductoscopy-assisted (DA) endosurgical interventions, combined with cytologic examinations. Success was determined by recurrence of PND and by standard radiological examinations.
RESULTS: Ductoscopy was successfully performed in 102 patients. Of these 102 patients, 26 had solitary papillomas (SP), 5 had multiple papillomas (MP), 11 had intraductal debris, and 1 had a ductal epithelial surface abnormality with positive cytology. Of the 26 polypoid lesions (cytology negative), 22 were excised endoscopically (endoscopic papillomectomy). Patients with MP underwent DA-microdochectomy. Except in one patient, all discharges disappeared. After a mean +/- SD follow-up time of 11.5 +/- 5.8 months (range 2-22 months), there were no recurrences of nipple discharge and no radiological results suggestive of malignancy. Thus, the therapeutic efficacy of EP in our study was 95.4% (21/22).
CONCLUSIONS: Ductoscopy is not only a diagnostic procedure, but is also therapeutic for breast papillomas. EP is a new scarless treatment option for patients with PND. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19295246     DOI: 10.1159/000195694

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  9 in total

Review 1.  Exploring breast with therapeutic ductoscopy.

Authors:  Fatih Levent Balci; Sheldon Marc Feldman
Journal:  Gland Surg       Date:  2014-05

2.  Intraductal approach to breast cancer: the role of mammary ductoscopy.

Authors:  Vinay Deshmane
Journal:  Indian J Surg Oncol       Date:  2011-03-22

3.  Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids.

Authors:  Weizhu Zhu; Wenyi Qin; John E Hewett; Edward R Sauter
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

Review 4.  Mammary ductoscopy in the current management of breast disease.

Authors:  Sarah S K Tang; Dominique J Twelves; Clare M Isacke; Gerald P H Gui
Journal:  Surg Endosc       Date:  2010-12-18       Impact factor: 4.584

5.  Patient-reported outcomes of ductoscopy procedures for pathologic nipple discharge.

Authors:  M D Filipe; J M Simons; L Moeliker; L Waaijer; M R Vriens; P J van Diest; A J Witkamp
Journal:  Breast Cancer       Date:  2020-11-12       Impact factor: 4.239

6.  Detection of breast cancer precursor lesions by autofluorescence ductoscopy.

Authors:  Laurien Waaijer; Mando D Filipe; Janine Simons; Carmen C van der Pol; Tjeerd de Boorder; Paul J van Diest; Arjen Joost Witkamp
Journal:  Breast Cancer       Date:  2020-07-28       Impact factor: 4.239

Review 7.  Multiple Papillomas of the Breast: A Review of Current Evidence and Challenges.

Authors:  Rossella Rella; Giovanna Romanucci; Damiano Arciuolo; Assunta Scaldaferri; Enida Bufi; Sebastiano Croce; Andrea Caulo; Oscar Tommasini
Journal:  J Imaging       Date:  2022-07-13

8.  Feasibility of Narrow-Band Imaging, Intraductal Biopsy, and Laser Ablation During Mammary Ductoscopy: Protocol for an Interventional Study.

Authors:  S Makineli; M D Filipe; F Euwe; A Sakes; J Dankelman; P Breedveld; M R Vriens; P J van Diest; A J Witkamp
Journal:  Int J Surg Protoc       Date:  2022-09-01

Review 9.  Meta-analysis and cost-effectiveness of ductoscopy, duct excision surgery and MRI for the diagnosis and treatment of patients with pathological nipple discharge.

Authors:  M D Filipe; S I S Patuleia; M R Vriens; P J van Diest; A J Witkamp
Journal:  Breast Cancer Res Treat       Date:  2021-01-21       Impact factor: 4.872

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.